Eko Health

Eko Health is a leading digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes, patient and provider software, and AI-powered analysis. Its FDA-cleared platform is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko Health is headquartered in Emeryville, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others. For more information visit www.ekohealth.com.

Eko exists to ensure all patients have access to early heart and lung disease detection that improves and extends their lives.

Eko Health headquartered in United States, North America, operates in the Software, Artificial Intelligence (AI), Machine Learning, Health Care, mHealth, Medical Device, Health Diagnostics sector. The company focuses on Software and has secured $52.1B in funding across 308 round(s). With a team of 101-250 employees, Eko Health is actively contributing to advancements in Software. Their latest funding round, Seed Round - Eko Health, raised $800.0K. Discover more about their projects, partnerships, and impact on our platform.